This ETF Lets You Benefit From Higher Oil Prices Without the Comedown — Positive
MLPA 24/7 Wall Street — April 03, 2026When geopolitical shocks send oil prices lurching higher, most energy investors reach for crude producers.
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report? — Positive
ELV Zacks Investment Research — April 03, 2026Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report? — Positive
REGN Zacks Investment Research — April 03, 2026Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will ATI (ATI) Beat Estimates Again in Its Next Earnings Report? — Positive
ATI Zacks Investment Research — April 03, 2026ATI (ATI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Polaris Inc (PII) Beat Estimates Again in Its Next Earnings Report? — Positive
PII Zacks Investment Research — April 03, 2026Polaris Inc (PII) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why KeyCorp (KEY) Could Beat Earnings Estimates Again — Positive
KEY Zacks Investment Research — April 03, 2026KeyCorp (KEY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Las Vegas Sands (LVS) Beat Estimates Again in Its Next Earnings Report? — Positive
LVS Zacks Investment Research — April 03, 2026Las Vegas Sands (LVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will The PNC Financial Services Group (PNC) Beat Estimates Again in Its Next Earnings Report? — Positive
PNC Zacks Investment Research — April 03, 2026The PNC Financial Services Group (PNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Virtu Financial (VIRT) Beat Estimates Again in Its Next Earnings Report? — Positive
VIRT Zacks Investment Research — April 03, 2026Virtu Financial (VIRT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Constellation Brands (STZ) Beat Estimates Again in Its Next Earnings Report? — Positive
STZ Zacks Investment Research — April 03, 2026Constellation Brands (STZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Matador (MTDR) Beat Estimates Again in Its Next Earnings Report? — Positive
MTDR Zacks Investment Research — April 03, 2026Matador (MTDR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will HF Sinclair (DINO) Beat Estimates Again in Its Next Earnings Report? — Positive
DINO Zacks Investment Research — April 03, 2026HF Sinclair (DINO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will U.S. Bancorp (USB) Beat Estimates Again in Its Next Earnings Report? — Positive
USB Zacks Investment Research — April 03, 2026U.S. Bancorp (USB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report? — Positive
CME Zacks Investment Research — April 03, 2026CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? — Positive
UTHR Zacks Investment Research — April 03, 2026United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Northern Trust (NTRS) Beat Estimates Again in Its Next Earnings Report? — Positive
NTRS Zacks Investment Research — April 03, 2026Northern Trust (NTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions — Neutral
PYPL GlobeNewsWire — April 03, 2026BENSALEM, Pa., April 03, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Shareholders who lost money in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Should Contact Wolf Haldenstein Immediately — Neutral
ALDX GlobeNewsWire — April 03, 2026NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors that a securities fraud class action lawsuit has been filed against Aldeyra Therapeutics, Inc., (“Aldeyra” or the "Company") (NASDAQ: ALDX) on behalf of investors that bought securities between November 3, 2023 and March 16, 2026, inclusive (the “Class Period”). Investors have until May 29, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
BLACKROCK TCP DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds BlackRock TCP Investors with Large Losses to Contact the Firm Before April 6th — Neutral
TCPC GlobeNewsWire — April 03, 2026Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BlackRock TCP (TCPC) To Contact Him Directly To Discuss Their Options
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know — Positive
SXTP Zacks Investment Research — April 03, 202660 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
